Plus Therapeutics Stock Forecast

Hold candidate since Jul 15, 2026

The Plus Therapeutics, Inc. stock price fell by -4.67% on the last day (Wednesday, 15th Jul 2026) from $4.28 to $4.08. During the last trading day the stock fluctuated 11.37% from a day low at $3.87 to a day high of $4.31. The price has fallen in 5 of the last 10 days and is down by -6.64% for this period. Volume has increased on the last day by 153 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 153 thousand shares were bought and sold for approximately $625.42 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -37.89% during the next 3 months and, with a 90% probability hold a price between $2.00 and $3.15 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

PSTV Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, July 08, 2026, and so far it has risen 6.81%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Plus Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $4.79. On a fall, the stock will find some support from the short-term average at $4.04. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Plus Therapeutics, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Plus Therapeutics, Inc. stock

Plus Therapeutics, Inc. finds support from accumulated volume at $4.05 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.440 between high and low, or 11.37%. For the last week, the stock has had daily average volatility of 7.76%.

Our recommended stop-loss: $3.96 (-2.94%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 5 days ago.)

Trading Expectations (PSTV) For The Upcoming Trading Day Of Thursday 16th

For the upcoming trading day on Thursday, 16th we expect Plus Therapeutics, Inc. to open at $4.09, and during the day (based on 14 day Average True Range), to move between $3.91 and $4.25, which gives a possible trading interval of +/-$0.349 (+/-8.94%) up or down from last closing price. If Plus Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 8.94% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.05 (0.74%) than the resistance at $4.17 (2.21%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Plus Therapeutics, Inc. stock A Buy?

Plus Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: 0.000 Hold/Accumulate Upgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on July 16, 2026 - $4.09 ( 0.164%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk